Consider Long-Term Unknown Effects of GLP-1 Usage One of the biggest reasons to consider stopping your use of GLP-1 medications is their unknown long-term effects
According to the Society for Endocrinology guidance, patients with suspected PBH should undergo formal assessment, which may include: Mixed-meal tolerance test to document postprandial glucose and insulin responses Continuous glucose monitoring over several days to identify patterns (though diagnosis requires capillary/venous glucose confirmation) Assessment for other causes of hypoglycaemia (insulinoma, adrenal insufficiency, hepatic dysfunction) Review of medications that may contribute to hypoglycaemia Patients should maintain a symptom diary documenting timing, food intake, and blood glucose readings when possible
The bottom line is that CRNAs must be hyper-vigilant in caring for patients prescribed GLP-1RAs
This single step reduces injection discomfort more than almost any other technique adjustment
Notably, there were no hepatic decompensations or increased side effects in the semaglutide group, suggesting that GLP-1 agonists are likely safe in compensated cirrhosis
Beta cells begin to show signs of stress, and their ability to increase insulin production reaches limits
.png.jpg)
